Trials / Sponsors / Yongxu Jia
Yongxu Jia
Academic / Other · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrosp Gastric Cancer, Gastroesophageal Junction Cancer, Immune Checkpoint Inhibitors (ICIs), Second-line | — | 2025-02-10 |
| Enrolling By Invitation | Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagog Gastric Neoplasm, Esophageal Adenosquamous Carcinoma | — | 2024-10-31 |
| Active Not Recruiting | A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma | Phase 2 | 2023-06-07 |